Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
Vietnam Investment Review on MSN17h
Everest Medicines Announces FDA Clearance of IND Application for Tumor Associated Antigen Vaccine EVM14EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...
Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximately ...
Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...
Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...
The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...
It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argue authors of a new essay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback